Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses

Pier Edoardo Rovatti, MD, Laura Zito, MSc, Eleonora Draghi, MSc, Monika Herrmann, PhD, Anetta Marcinek, MSc, Bettina Brauchle, MSc, Cesare Covino, MSc, Mattia Di Bono, MSc, Matteo Giovanni Carrabba, MD, Massimo Bernardi, MD, Karl-Peter Hopfner, PhD, Cristina Toffalori, PhD, Fabio Ciceri, MD, Marion Subklewe, MD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 513.

https://doi.org/10.1182/blood-2019-126641

Published: 2019

Journal Articles

Mapping the Evolution of the Mutational Landscape of Acute Myeloid Leukemia from Diagnosis to Post-Transplantation Relapse and Its Interplay with Immune Evasion Mechanisms

Elisa Sala, MD, Francesca Biavasco, MD, Gabriele Bucci, PhD, Cristina Toffalori, PhD, Donatella Biancolini, PhD, Elena Antonini, MSc, Matteo Giovanni Carrabba, MD, Bernhard Gentner, MD, Cristina Tresoldi, MSc, Massimo Bernardi, MD, Dejan Lazarevic, MD, Giovanni Tonon, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2019) 134 (Supplement_1): 511.

https://doi.org/10.1182/blood-2019-124725

Published: 2019

Journal Articles

Early and Profound Exhausted Phenotype of Central Memory and Memory Stem T Cells in the Bone Marrow of AML Patients Characterizes and Predicts Relapse after Allo-HSCT

Maddalena Noviello, PhD, Francesco Manfredi, MD, Tommaso Perini, MD, Oliveira Giacomo, PhD, Filippo Cortesi, PhD, Pantaleo De Simone, MD, Cristina Toffalori, PhD, Valentina Gambacorta, MSc, Attilio Bondanza, MD, Raffaella Greco, MD, Jacopo Peccatori, MD, Giulia Casorati, PhD, Paolo Dellabona, MD PhD, Nicoletta Cieri, MD PhD, Luca Vago, MD PhD, Fabio Ciceri, MD, Chiara Bonini, MD

Blood (2017) 130 (Supplement 1): 4491.

https://doi.org/10.1182/blood.V130.Suppl_1.4491.4491

Published: 2017

Journal Articles

Multiple Inhibitory Receptors Are Expressed on Central Memory and Memory Stem T Cells Infiltrating the Bone Marrow of AML Patients Relapsing after Allo-HSCT

Maddalena Noviello, PhD, Francesco Manfredi, Tommaso Perini, MD, Giacomo Oliveira, PhD, Filippo Cortesi, PhD, Cristina Toffalori, PhD, Valentina Gambacorta, MSc, Attilio Bondanza, MD PhD, Raffaella Greco, MD, Jacopo Peccatori, MD, Giulia Casorati, PhD, Paolo Dellabona, PhD, Nicoletta Cieri, MD PhD, Luca Vago, MD PhD, Fabio Ciceri, MD, Chiara Bonini, MD

Blood (2016) 128 (22): 4564.

https://doi.org/10.1182/blood.V128.22.4564.4564

Published: 2016

Journal Articles

Natural Killer Cell Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide: Elimination of Donor-Derived Mature Alloreactive NK Cells, but Favorable Conditions for Adoptive Immunotherapy

Antonio Russo, Giacomo Oliveira, PhD, Sofia Berglund, MD PhD, Raffaella Greco, MD, Valentina Gambacorta, MSc, Nicoletta Cieri, MD PhD, Cristina Toffalori, PhD, Laura Zito, MSc, Simona Piemontese, MD, Mara Morelli, MD, Fabio Giglio, MD, Andrea Angelo Assanelli, MD, Maria Teresa Lupo Stanghellini, MD, Chiara Bonini, MD, Jacopo Peccatori, MD, Leo Luznik, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2016) 128 (22): 4567.

https://doi.org/10.1182/blood.V128.22.4567.4567

Published: 2016

Journal Articles

Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts

Giacomo Oliveira, PhD, Gabriele Bucci, PhD, Cristina Toffalori, PhD, Carolina Caserta, Lara Crucitti, MD, Barbara Camisa, BSc, Raffaella Greco, MD, Francesca Biavasco, Lucia Zanotti, PhD, Laura Zito, MSc, Jose Manuel Garcia-Manteiga, PhD, Dejan Lazarevic, MD, Matteo Giovanni Carrabba, MD, Massimo Bernardi, MD, Attilio Bondanza, MD PhD, Chiara Bonini, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2016) 128 (22): 2858.

https://doi.org/10.1182/blood.V128.22.2858.2858

Published: 2016

Journal Articles

HLA Loss Leukemia Relapses after Partially-Incompatible Allogeneic HSCT As a Prototypical System to Investigate Natural Killer Cell Dynamics

Valentina Gambacorta, MSc, Giacomo Oliveira, PhD, Laura Zito, MSc, Cristina Toffalori, PhD, Lara Crucitti, MD, Maddalena Noviello, PhD, Benedetta Mazzi, MSc, Raffaella Greco, MD, Maria Teresa Lupo Stanghellini, MD, Matteo G Carrabba, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Katharina Fleischhauer, MD, Chiara Bonini, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2015) 126 (23): 743.

https://doi.org/10.1182/blood.V126.23.743.743

Published: 2015

Journal Articles

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Cristina Toffalori, PhD, Michela Riba, PhD, Laura Zito, BSc, Matteo Barcella, MSc, Orietta Spinelli, PhD, Lara Crucitti, MD, Nicoletta Cieri, MD PhD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Alessandro Rambaldi, Cristina Barlassina, BSc, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Luca Vago, MD PhD

Blood (2014) 124 (21): 427.

https://doi.org/10.1182/blood.V124.21.427.427

Published: 2014

Journal Articles

Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion

Blood (2014) 124 (21): 1185.

https://doi.org/10.1182/blood.V124.21.1185.1185

Published: 2014

Journal Articles

Droplet Digital PCR for DNMT3A and IDH1/2 Mutations to Improve Early Diagnosis of Acute Myeloid Leukemia Relapse after Allogeneic HSCT

Chiara Brambati, BSc, Cristina Toffalori, PhD, Elisabetta Xue, MS, Lara Crucitti, MD, Raffaella Greco, MD, Alessandra Crippa, BSc, Benedetta Mazzi, MSc, Cristina Tresoldi, MSc, Silvia Galbiati, BSc, Chiara Bonini, MD, Jacopo Peccatori, MD, Matteo G Carrabba, MD, Massimo Bernardi, MD, Maurizio Ferrari, MD, Vito Lampasona, PhD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2014) 124 (21): 3951.

https://doi.org/10.1182/blood.V124.21.3951.3951

Published: 2014

Journal Articles

Modeling Antileukemic Adoptive Immunotherapy In Mouse-Humans Chimeras To Identify Novel Mechanisms Of Cancer Immunoediting

Giacomo Oliveira, MSc, Cristina Toffalori, PhD, Jose Manuel Garcia-Manteiga, PhD, Barbara Camisa, BSc, Lara Crucitti, MD, Dejan Lazarevic, MD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Claudio Bordignon, MD, Attilio Bondanza, MD, PhD, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Chiara Bonini, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 2017.

https://doi.org/10.1182/blood.V122.21.2017.2017

Published: 2013

Journal Articles

Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT

Cristina Toffalori, PhD, Michela Riba, PhD, Matteo Barcella, MSc, Orietta Spinelli, PhD, Lara Crucitti, MD, Jacopo Peccatori, MD, Massimo Bernardi, MD, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Alessandro Rambaldi, MD, Cristina Barlassina, BSc, Elia Stupka, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 3748.

https://doi.org/10.1182/blood.V122.21.3748.3748

Published: 2013

Journal Articles

High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants

Luca Vago, MD, PhD, Benedetta Mazzi, BSc, Lorenza Chiesa, BSc, Raffaella Greco, MD, Cinzia Pultrone, MSc, Eleonora Toffoletti, MD, Cristina Toffalori, PhD, Pietro Crivello, PhD, Veronica Tettamanzi, MSc, Lara Crucitti, MD, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Chiara Bonini, MD, Douglas A. Bost, PhD, Fabio Ciceri, MD, Katharina Fleischhauer, MD

Blood (2013) 122 (21): 3313.

https://doi.org/10.1182/blood.V122.21.3313.3313

Published: 2013

Journal Articles

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Luca Vago, MD, PhD, Davide Cittaro, PhD, Dejan Lazarevic, MD, Cristina Toffalori, PhD, Giacomo Oliveira, MSc, Lorenza Chiesa, BSc, Benedetta Mazzi, BSc, Maurilio Ponzoni, MD, Matteo Carrabba, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD, Elia Stupka, PhD

Blood (2013) 122 (21): 1369.

https://doi.org/10.1182/blood.V122.21.1369.1369

Published: 2013

Journal Articles

Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation

Lara Crucitti, MD, Roberto Crocchiolo, MD, PhD, Cristina Toffalori, PhD, Maria Teresa Lupo Stanghellini, MD, Andrea Assanelli, MD, Matteo Carrabba, MD, Benedetta Mazzi, BSc, Elisabetta Zino, BSc, Sarah Marktel, MD, Magda Marcatti, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Claudio Bordignon, MD, Chiara Bonini, MD, Katharina Fleischhauer, MD, Fabio Ciceri, MD, Luca Vago, MD, PhD

Blood (2013) 122 (21): 918.

https://doi.org/10.1182/blood.V122.21.918.918

Published: 2013

NARROW

Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses

Mapping the Evolution of the Mutational Landscape of Acute Myeloid Leukemia from Diagnosis to Post-Transplantation Relapse and Its Interplay with Immune Evasion Mechanisms

Early and Profound Exhausted Phenotype of Central Memory and Memory Stem T Cells in the Bone Marrow of AML Patients Characterizes and Predicts Relapse after Allo-HSCT

Multiple Inhibitory Receptors Are Expressed on Central Memory and Memory Stem T Cells Infiltrating the Bone Marrow of AML Patients Relapsing after Allo-HSCT

Natural Killer Cell Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide: Elimination of Donor-Derived Mature Alloreactive NK Cells, but Favorable Conditions for Adoptive Immunotherapy

Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts

HLA Loss Leukemia Relapses after Partially-Incompatible Allogeneic HSCT As a Prototypical System to Investigate Natural Killer Cell Dynamics

Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation

Backtracking Leukemia Clonal Evolution from Post-Transplantation Relapse to Initial Diagnosis to Identify Founder Mutations and Mechanisms of Immune Evasion

Droplet Digital PCR for DNMT3A and IDH1/2 Mutations to Improve Early Diagnosis of Acute Myeloid Leukemia Relapse after Allogeneic HSCT

Modeling Antileukemic Adoptive Immunotherapy In Mouse-Humans Chimeras To Identify Novel Mechanisms Of Cancer Immunoediting

Identification By Gene Expression Profiling Of CIITA-Dependent HLA Class II Transcriptional Downregulation As a Novel Mechanism Of Leukemia Immune Escape and Relapse After Allogeneic HSCT

High-Sensitivity Hematopoietic Chimerism By qPCR For Relapse Prediction and Specific Identification Of HLA Loss Leukemic Variants

Non-Linear Clonal Evolution Of Leukemia Driven By Selective Immune Pressure and Revealed By HLA Typing and High-Depth Exome Sequencing

Incidence, Risk Factors and Clinical Outcome Of Leukemia Relapses Due To Loss Of The Mismatched HLA Haplotype After Partially-Incompatible Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only